Elutia (ELUT) Cash from Investing Activities (2019 - 2026)
Elutia (ELUT) posted Cash from Investing Activities of -$34000.0 for Q1 2026, down 100.04% sequentially from $79.6 million in Q4 2025, and up 87.77% YoY from -$18107.3 in Q1 2025.
Elutia (ELUT) Cash from Investing Activities (2019 - 2026) Analysis & Trends
Elutia has reported Cash from Investing Activities for 8 years, with the latest figure at -$34000.0 in Q1 2026.
- Quarterly Cash from Investing Activities rose 87.77% year-over-year to -$34000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $78.8 million (up 10792.4% YoY) and the FY2025 annual result came in at $78.6 million, up 16673.63% from the prior year.
- Cash from Investing Activities slipped to -$34000.0 in Q1 2026 per ELUT's latest filing, from $79.6 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $79.6 million in Q4 2025 and troughed at -$630000.0 in Q3 2025.
- A 5-year average of $5.4 million and a median of -$94000.0 in 2024 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 84760.64% in 2025, down 1753.33% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$134000.0 in 2022, then surged by 10948.51% to $14.5 million in 2023, then plunged by 100.65% to -$94000.0 in 2024, then surged by 84760.64% to $79.6 million in 2025, then slumped by 100.04% to -$34000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$34000.0, $79.6 million, and -$630000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.37 Bn | 193.76 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.75 Bn | 124.27 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.07 Bn | 109.85 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.64 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.90 Bn | 31.79 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.38 Bn | 23.06 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Elutia | 40.24 Mn | 20.35 Mn | 1.45 Mn | -91,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34,000.00 |
| Mar 31, 2026 | -34,000.00 |
| Dec 31, 2025 | 79.58 Mn |
| Dec 31, 2025 | 79.58 Mn |
| Sep 30, 2025 | -630,000.00 |
| Sep 30, 2025 | -630,000.00 |
| Jun 30, 2025 | -114,000.00 |
| Jun 30, 2025 | -114,000.00 |
| Mar 31, 2025 | -278,000.00 |
| Mar 31, 2025 | -278,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Sep 30, 2024 | -547,000.00 |
| Sep 30, 2024 | -547,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | -15,000.00 |
| Mar 31, 2024 | -15,000.00 |
| Dec 31, 2023 | 14.54 Mn |
| Dec 31, 2023 | 14.54 Mn |